UNSPSC 51384601: Dipyrone or metamizol or metamizole

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H16N3O4S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6429L0L52Y, chemically known as 4-methylamino-1,5-dimethyl-2-phenyl-3-pyrazolone sodium methanesulfonate but generally known as dipyrone, which bears US NIH Compound Identifier 6236. European Medicines Agency schedules Dipyrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08810MIG. SMILES: S(=O)(=O)(O)CN(C1C(N(N(C1=O)C1CCCCC1)C)C)C.[NA].

UNSPSC 51384601 Dipyrone or metamizol or metamizole is a Commodity code, but the recent state and local opportunities posted under it do not involve dipyrone or related analgesics — instead, they center on naloxone procurement, direct-to-manufacturer pharmacy programs, and multi-source generic pharmaceuticals through cooperative purchasing vehicles. The mismatch suggests the code shows little activity aligned with its nominal pharmaceutical scope in current state and local solicitations.

The three recent opportunities span different issuing-body types and procurement strategies. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with a response deadline of July 26, 2023 (note: the due date appears inconsistent with the posting date). The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager and wholesaler channels — a market-intelligence phase preceding formal solicitation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026, with a response deadline of March 26, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson). Activity spans Florida, Texas, and Minnesota, with MMCAP's reach extending to participating state and local facilities including Oregon. The code's misalignment with posted opportunities and the absence of dipyrone-specific solicitations suggest limited current state and local demand under this Commodity code.